Toggle navigation
Home
Medical
Trametinib: New Go-To for Low-Grade Serous Ovarian Carcinoma?
10-2-2022
Medical
https://www.medscape.com/cx/rssfeeds/2700.xml
79
For the first time, a randomized trial has reported positive results in patients with this particular type of ovarian cancer. Medscape Medical News
Share
Tweet
+1
Read The Rest
at : https://www.medscape.com/cx/rssfeeds/2700.xml
Related News
Machine learning models predict hepatocellular carcinoma...
Kinase activity in renal cell carcinoma, benign renal...
AGA recommends shared decision-making approach for...
Biomarkers in Saliva May Detect Hepatocellular Carcinoma
Online tool helps ovarian cancer patients feel more in...
Could Pap smears one day help detect breast and ovarian...
Reduced-dose RT with Cisplatin improves outcomes for...
Potentially promising therapeutic combination for renal...
Researchers uncover potentially promising therapeutic...
Study: Menopause symptoms are worse for women with...